APAC IPOs & Placements, Aequitas Research

Clarence Chu

At Aequitas we cover all IPOs and placements across Asia-Pac with a deal size of at least US$100m. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

APAC IPOs & Placements

Telix Pharmaceutical US ADS - Momentum Remains Strong, Offering Would Triple Its Cash Base

Telix Pharmaceutical US ADS - Past Deal Record Hasn't Been Strong, but Fortune Could Be Turning

Super Hi International US ADS - Has Been Doing Well but Doesn’t Really Need the Cash

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

Tamboran Resources / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/tamboran-resources-ltd" target="_blank" data-smartkarma-citation="entities:35101:1" rel="noopener">Tamboran Resources (TBN AU)</a> is looking to raise US$175m from listing its shares in the US.</li>
<li>Tamboran Resources is an early stage, independent natural gas exploration and production company.</li>
<li>In this note, we talk about the deal dynamics and the listing impact.</li>
</ul>



Tamboran Resources (TBN AU) is looking to raise US$175m from listing its shares in the US.
Tamboran Resources is an early stage, independent natural gas exploration and production company.
In this note, we talk about the deal dynamics and the listing impact.


Tamboran Resources US Offering - Strong Recent Momentum but CDIs Have Been Volatile Since Listing